EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Predicting cardiovascular morbidity and mortality with SCORE2 (OP) and Framingham risk estimates in combination with indicators of biological ageing

Anna Tirkkonen, Jonathan K L Mak, Johan G Eriksson, Pauliina Halonen iD, Juulia Jylhävä iD, Sara Hägg, Linda Enroth iD, Jani Raitanen, Iiris Hovatta, Tuija Jääskeläinen, Seppo Koskinen, Markus J Haapanen iD und 2 weitere

Age and Ageing · 2025

DOI: 10.1093/ageing/afaf075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, 2025. Verfasst von Anna Tirkkonen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Sport and Health Sciences and Gerontology Research Center, University of Jyväskylä, Jyväskylä, Finland. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Aging, Frailty. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Previous research assessing whether biological ageing (BA) indicators can enhance the risk assessment of cardiovascular disease (CVD) outcomes beyond established CVD risk indicators, such as Framingham Risk Score (FRS) and Systematic Coronary Risk Evaluation (SCORE2)/SCORE2-Older Persons (OP), is scarce. We explored whether BA indicators, namely the Rockwood Frailty Index (FI) and leukocyte telomere length (TL), improve predictive accuracy of CVD outcomes beyond the traditional CVD risk indicators in general population of middle-aged and older CVD-free individuals.

Methods

Data included 14 118 individuals from three population-based cohorts: TwinGene, Health 2000 (H2000), and the Helsinki Birth Cohort Study, grouped by baseline age (<70, 70+). The outcomes were incident CVD and CVD mortality with 10-year follow-up. Risk estimations were assessed using Cox regression and predictive accuracies with Harrell’s C-index.

Results

Across the three study cohorts and age groups: (i) a higher FI, but not TL, was associated with a higher occurrence of incident CVD (P < .05), (ii) also when considering simultaneously the baseline CVD risk according to FRS or SCORE2/SCORE2-OP (P < .05) (iii) adding FI to the FRS or SCORE2/SCORE2-OP model improved the predictive accuracy of incident CVD. Similar findings were seen for CVD mortality, but less consistently across the cohorts.

Conclusions

We show robust evidence that a higher FI value at baseline is associated with an increased risk of incident CVD in middle-aged and older CVD-free individuals, also when simultaneously considering the risk according to the FRS or SCORE2/SCORE2-OP. The FI improved the predictive accuracy of CVD outcomes beyond the traditional CVD risk indicators and demonstrated satisfactory predictive accuracy even when used independently.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesAgingFrailtyHumansMaleAgedFemaleRisk AssessmentMiddle AgedPredictive Value of TestsAge FactorsHeart Disease Risk FactorsIncidenceFinlandAged, 80 and overPrognosisTelomere HomeostasisTelomereRisk FactorsTime Factors

Stichwörter der Autor:innen

biological ageingcardiovascular disease (CVD) riskfrailty-indexolder peoplesystematic coronary risk evaluation (SCORE2)telomere length

Autor:innen und Institutionen

  • Faculty of Sport and Health Sciences and Gerontology Research Center, University of Jyväskylä, Jyväskylä, Finland.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
  • Department of Pharmacology and Pharmacy, The University of Hong Kong, Hong Kong, China.
  • Folkhälsan Research Center, Public Health Programme, Helsinki, Finland.
  • Department of General Practice and Primary Health Care, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Department of Obstetrics and Gynaecology and Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.

ORCID-Profile: Pauliina Halonen, Juulia Jylhävä, Linda Enroth, Markus J Haapanen

Zitieren

APA

Tirkkonen, A., Mak, J. K. L., Eriksson, J. G., Halonen, P., Jylhävä, J., Hägg, S., Enroth, L., Raitanen, J., Hovatta, I., Jääskeläinen, T., Koskinen, S., Haapanen, M. J., von Bonsdorff, M. B., & Kananen, L. (2025). Predicting cardiovascular morbidity and mortality with SCORE2 (OP) and Framingham risk estimates in combination with indicators of biological ageing. Age and Ageing. https://doi.org/10.1093/ageing/afaf075

Vancouver

Tirkkonen A, Mak JKL, Eriksson JG, Halonen P, Jylhävä J, Hägg S, et al. Predicting cardiovascular morbidity and mortality with SCORE2 (OP) and Framingham risk estimates in combination with indicators of biological ageing. Age and Ageing. 2025. doi:10.1093/ageing/afaf075

BibTeX
@article{Tirkkonen2025,
  author = {Tirkkonen, Anna and Mak, Jonathan K L and Eriksson, Johan G and Halonen, Pauliina and Jylhävä, Juulia and Hägg, Sara and Enroth, Linda and Raitanen, Jani and Hovatta, Iiris and Jääskeläinen, Tuija and Koskinen, Seppo and Haapanen, Markus J and von Bonsdorff, Mikaela B and Kananen, Laura},
  title = {Predicting cardiovascular morbidity and mortality with SCORE2 (OP) and Framingham risk estimates in combination with indicators of biological ageing},
  journal = {Age and Ageing},
  year = {2025},
  doi = {10.1093/ageing/afaf075}
}
Kostenlos starten →